(Q43785359)

26 November 2017

title

In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations (English)

1 reference

Stenotrophomonas maltophilia

26 November 2017

main subject

1 reference

Krueger TS

1

1 reference

26 November 2017

Clark EA

series ordinal

2

1 reference

26 November 2017

Nix DE

series ordinal

3

1 reference

26 November 2017

publication date

1 September 2001

1 reference

26 November 2017

number of pages

8

1 reference

Diagnostic Microbiology and Infectious Disease

inferred from page(s)

published in

1 reference

26 November 2017

volume

41

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

71-78

1 reference

A functional classification scheme for beta-lactamases and its correlation with molecular structure

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

Comparison of various in vitro susceptibility methods for testing Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900281-4

7 January 2021

10.1016/S0732-8893(01)00281-4

Identifiers

DOI

1 reference

26 November 2017

1 reference